Author: BusinessWire

Proceeds to further accelerate AI drug discovery platform and pipeline
OXFORD, England–(BUSINESS WIRE)–Exscientia, a clinical stage pharmatech pioneering the use of artificial intelligence (AI) to design new drugs, today announced that funds managed…

Be The Match BioTherapies will provide streamlined supply chain services in support of Orchard’s commercial-stage gene therapy in Europe
MINNEAPOLIS–(BUSINESS WIRE)–Be The Match BioTherapies, an organization offering solutions for companies developi…

MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that …

MINNETONKA, Minn.–(BUSINESS WIRE)–#COVID19vaccine–Nu-Tek BioSciences, LLC, an innovative manufacturer of industrial ingredients used in the development and manufacturing of pharmaceuticals, announced today that the company will build a new manufactu…

While the Short-term Impact of COVID-19 Remains Limited Within Pricing & Contracting, a Shift in Medicaid Enrollment Could Create Modeling Challenges, According to the New TGaS Report from Trinity Life Sciences
WALTHAM, Mass.–(BUSINESS WIRE)–Tri…

− Organizational change positions NorthStar for next stage of growth and ongoing U.S. molybdenum-99 (Mo-99) production expansion −

− NorthStar poised to be first commercial-scale supplier of important therapeutic radioisotopes Copper-67 (Cu-67) and A…

CAMBRIDGE, Mass. & LAUSANNE, Switzerland–(BUSINESS WIRE)–Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that Kristin Neff, vice president, clinical operations of …

DUBLIN–(BUSINESS WIRE)–The “Traumatic Brain Injury – Market Insight, Epidemiology and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report deliver an in-depth understanding of the Traumatic Brain In…

Sleep A.S.A.P. provides proof of concept and monetization for CURE’s patented oral thin-film technology
LOS ANGELES & OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, verti…

BERKELEY, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today the successful completion of an oversubscribed $115 million Series C financing. Proceeds from the financ…